2-Hydroxysagamicin: a new antibiotic produced by mutational biosynthesis of Micromonospora sagamiensis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000096:biosynthesis* / Q000494:pharmacology; D001412:Bacillus subtilis / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D005839:Gentamicins / Q000032:analysis / Q000096:biosynthesis* / Q000494:pharmacology; D007928:Lethal Dose 50; D051379:Mice; D008847:Micromonospora / Q000235:genetics / Q000378:metabolism*; D009154:Mutation
D000900:Anti-Bacterial Agents; D005839:Gentamicins; C033977:2-hydroxysagamicin